Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rotter

Showing results (71-80 of 161) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995
Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced formR Wolkowicz, A Peled, N B Elkind, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 7, 2005
The effect of PPARgamma ligands on the adipose tissue in insulin resistanceA Hammarstedt, C X Andersson, V Rotter Sopasakis, et al.
Oncogene|December 17, 1997
Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repairD Schwartz, N Almog, A Peled, et al.
Molecular Carcinogenesis|July 1, 1995
p53 mutations in matched primary and metastatic human tumorsS Peller, A Halevy, S Slutzki, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1996
Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levelsD Ronen, D Schwartz, Y Teitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Variation in antigenic determinants of p53 transformation-related protein obtained from various speciesV Rotter, H Friedman, A Katz, et al.
Oncogene|January 1, 1987
Inhibition of cell growth mediated by plasmids encoding p53 anti-senseO Shohat, M Greenberg, D Reisman, et al.
Oncogene|August 25, 2001
The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosisA Sigal, D Matas, N Almog, et al.
Oncology Reports|December 29, 1998
Polymorphisms of the p53 gene in women with ovarian or endometrial carcinomaS Peller, R Halperin, D Schneider, et al.
Leukemia & Lymphoma|June 27, 1998
P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrationsM Prokocimer, S Peller, H Ben-Bassat, et al.
Pageof 17

Showing results (71-80 of 161) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995
Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced formR Wolkowicz, A Peled, N B Elkind, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 7, 2005
The effect of PPARgamma ligands on the adipose tissue in insulin resistanceA Hammarstedt, C X Andersson, V Rotter Sopasakis, et al.
Oncogene|December 17, 1997
Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repairD Schwartz, N Almog, A Peled, et al.
Molecular Carcinogenesis|July 1, 1995
p53 mutations in matched primary and metastatic human tumorsS Peller, A Halevy, S Slutzki, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1996
Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levelsD Ronen, D Schwartz, Y Teitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Variation in antigenic determinants of p53 transformation-related protein obtained from various speciesV Rotter, H Friedman, A Katz, et al.
Oncogene|January 1, 1987
Inhibition of cell growth mediated by plasmids encoding p53 anti-senseO Shohat, M Greenberg, D Reisman, et al.
Oncogene|August 25, 2001
The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosisA Sigal, D Matas, N Almog, et al.
Oncology Reports|December 29, 1998
Polymorphisms of the p53 gene in women with ovarian or endometrial carcinomaS Peller, R Halperin, D Schneider, et al.
Leukemia & Lymphoma|June 27, 1998
P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrationsM Prokocimer, S Peller, H Ben-Bassat, et al.
Pageof 17